PFENYSEPharmaceutical PreparationsFiscal year ends December 31
PFIZER INC
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026
$29.44−0.14 (-0.47%)
Close on Oct 19, 2026
- Market cap
- $167.78B
- P/E (TTM)
- 38.7
- Dividend yield
- 5.84%
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
67.2%
3.83B of 5.70B shares
Institutional holders
2,823
155 new, 235 sold out
Net institutional buying
76M
In Q2 2026
Insider trades, 12 months
3 buys · 2 sales
Net bought $2.83M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 434,748,255 | 7.70% | 13G (passive) amendment | Dec 31, 2023 |
| Vanguard Capital Management | 427,444,872 | 7.51% | 13G (passive) | Mar 31, 2026 |
| State Street Corporation | – | 5.10% | 13G (passive) amendment | Dec 31, 2023 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of PFE | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 529,670,433 | 9.29% | $12.75B | +31,412,883 | 0.19% |
| Vanguard Capital Management LLC | 372,149,852 | 6.53% | $8.96B | +2,719,840 | 0.19% |
| State Street Corp | 307,090,897 | 5.39% | $7.39B | +5,501,032 | 0.22% |
| Geode Capital Management, LLC | 135,275,782 | 2.37% | $3.25B | +1,714,040 | 0.17% |
| Vanguard Portfolio Management LLC | 119,235,030 | 2.09% | $2.87B | +2,500,335 | 0.13% |
| Fisher Asset Management, LLC | 109,067,291 | 1.91% | $2.63B | +4,102,864 | 0.78% |
| Morgan Stanley | 96,345,452 | 1.69% | $2.32B | +3,660,082 | 0.12% |
| Norges Bank | 61,505,586 | 1.08% | $1.48B | New | 0.15% |
| Northern Trust Corp | 59,084,573 | 1.04% | $1.42B | −2,941,979 | 0.17% |
| Bank of New York Mellon Corp | 57,879,546 | 1.02% | $1.39B | +3,999,646 | 0.23% |
| Massachusetts Financial Services Co /Ma/ | 56,551,011 | 0.99% | $1.38B | −360,819 | 0.44% |
| State Farm Mutual Automobile Insurance Co | 54,508,560 | 0.96% | $1.31B | – | 0.90% |
| Goldman Sachs Group Inc | 52,991,850 | 0.93% | $1.28B | +5,886,294 | 0.11% |
| Charles Schwab Investment Management Inc | 52,548,228 | 0.92% | $1.27B | +656,592 | 0.17% |
| Bank Of America Corp /De/ | 43,588,109 | 0.76% | $1.05B | −2,957,370 | 0.07% |
| Legal & General Group Plc | 43,233,122 | 0.76% | $1.04B | −272,441 | 0.22% |
| Dimensional Fund Advisors LP | 38,060,345 | 0.67% | $916.63M | +1,637,546 | 0.17% |
| UBS Asset Management Americas Inc | 36,157,306 | 0.63% | $870.67M | +1,634,374 | 0.16% |
| Amundi | 33,533,616 | 0.59% | $807.49M | −7,291,854 | 0.19% |
| Royal Bank of Canada | 32,814,260 | 0.58% | $790.17M | −1,341,580 | 0.12% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2,823 | 3.83B | 67.2% | 155 / 1160 | 1213 / 235 | 270M | 194M |
| Q1 2026 | 2,955 | 3.76B | 66.0% | 256 / 1306 | 1087 / 169 | 779M | 222M |
| Q4 2025 | 2,915 | 3.75B | 65.9% | 329 / 1080 | 1268 / 172 | 309M | 207M |
| Q3 2025 | 2,818 | 3.66B | 64.2% | 206 / 1123 | 1221 / 152 | 205M | 299M |
| Q2 2025 | 2,814 | 3.76B | 66.0% | 143 / 1181 | 1232 / 230 | 241M | 228M |
| Q1 2025 | 2,936 | 3.76B | 65.9% | 181 / 1283 | 1203 / 189 | 342M | 319M |
| Q4 2024 | 2,999 | 3.76B | 65.9% | 379 / 937 | 1468 / 246 | 262M | 295M |
| Q3 2024 | 2,916 | 3.80B | 66.7% | 193 / 1241 | 1204 / 124 | 627M | 178M |
| Q2 2024 | 2,879 | 3.79B | 66.4% | 211 / 1187 | 1242 / 173 | 178M | 394M |
| Q1 2024 | 2,880 | 4.01B | 70.4% | 193 / 1226 | 1248 / 218 | 318M | 306M |
| Q4 2023 | 2,940 | 4.01B | 70.3% | 329 / 869 | 1588 / 270 | 333M | 239M |
| Q3 2023 | 2,931 | 3.92B | 68.7% | 127 / 1190 | 1386 / 207 | 168M | 179M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of PFE | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 180,944,898 | 3.17% | $4.36B | 0.19% | Jun 30, 2026 |
| Vanguard 500 Index Fund | 147,700,066 | 2.59% | $3.56B | 0.21% | Jun 30, 2026 |
| iShares Core S&P 500 ETF | 78,364,949 | 1.37% | $1.89B | 0.21% | Jun 30, 2026 |
| Fidelity 500 Index Fund | 72,760,111 | 1.28% | $1.90B | 0.23% | May 31, 2026 |
| Vanguard Value Index Fund | 54,248,096 | 0.95% | $1.31B | 0.51% | Jun 30, 2026 |
| State Street(R) Health Care Select Sector SPDR(R) ETF | 40,264,803 | 0.71% | $969.58M | 2.39% | Jun 30, 2026 |
| Vanguard Institutional Index Fund | 30,941,396 | 0.54% | $745.07M | 0.21% | Jun 30, 2026 |
| iShares Core High Dividend ETF | 25,420,952 | 0.45% | $635.78M | 4.27% | Jul 31, 2026 |
| Vanguard High Dividend Yield Index Fund | 22,923,592 | 0.40% | $573.32M | 0.58% | Jul 31, 2026 |
| iShares Select Dividend ETF | 18,810,080 | 0.33% | $470.44M | 2.00% | Jul 31, 2026 |
| First Trust Morningstar Dividend Leaders Index Fund | 17,883,531 | 0.31% | $430.64M | 5.91% | Jun 30, 2026 |
| Vanguard Health Care Index Fund | 17,075,747 | 0.30% | $447.04M | 2.35% | May 31, 2026 |
| MFS Value Fund | 15,033,063 | 0.26% | $393.57M | 0.77% | May 31, 2026 |
| New Perspective Fund | 14,451,200 | 0.25% | $347.98M | 0.20% | Jun 30, 2026 |
| Pacer US Cash Cows 100 ETF | 13,728,675 | 0.24% | $343.35M | 1.84% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Albert Bourla | Chairman & CEO, Director | 435,555 | 0.01% | Sep 16, 2026 |
| Cecile Guegan | Executive Vice President | 149,505 | 0.00% | Aug 28, 2026 |
| Jennifer B. Damico | SVP & Controller | 28,611 | 0.00% | Aug 6, 2026 |
| Dennis P. Hancock | Executive Vice President | 47,037 | 0.00% | Apr 27, 2026 |
| Payal Sahni | Executive Vice President | 97,446 | 0.00% | Mar 5, 2026 |
| David M. Denton | Chief Financial Officer & EVP | 37,919 | 0.00% | Mar 5, 2026 |
| Andrew Baum | Executive Vice President | – | – | Mar 5, 2026 |
| Christoffel Boshoff | President, R&D | 168,921 | 0.00% | Mar 5, 2026 |
| Douglas M. Lankler | Executive Vice President | 284,269 | 0.00% | Mar 5, 2026 |
| Michael McDermott | Executive Vice President | 74,308 | 0.00% | Mar 5, 2026 |
| Aamir Malik | Executive Vice President | 29,548 | 0.00% | Mar 5, 2026 |
| Germay Alexandre de | Executive Vice President | 74,377 | 0.00% | Mar 5, 2026 |
| Lidia Fonseca | Executive Vice President | 46,455 | 0.00% | Mar 5, 2026 |
| Sally Susman | Executive Vice President | 169,775 | 0.00% | Mar 6, 2025 |
| Rady A. Johnson | Executive Vice President | 127,242 | 0.00% | Jan 3, 2025 |
| James Quincey | Director | – | – | Sep 29, 2026 |
| Mortimer J. Buckley | Director | 37,632 | 0.00% | Sep 29, 2026 |
| Joseph Echevarria | Director | – | – | Sep 29, 2026 |
| Shantanu Narayen | Director | – | – | Sep 29, 2026 |
| James C. Smith | Director | 3,542 | 0.00% | Sep 29, 2026 |
| Cyrus Taraporevala | Director | 10,000 | 0.00% | Sep 29, 2026 |
| Ronald E. Blaylock | Director | 71,688 | 0.00% | Aug 5, 2026 |
| Dan R. Littman | Director | – | – | Apr 27, 2026 |
| Susan Desmond-Hellmann | Director | 3,408 | 0.00% | Apr 27, 2026 |
| Johnson Suzanne M. Nora | Director | 10,000 | 0.00% | Apr 27, 2026 |
| Scott Gottlieb | Director | 10,000 | 0.00% | Apr 27, 2026 |
| Susan Hockfield | Director | – | – | Apr 28, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Albert Bourla Chairman & CEO, Director | Aug 12, 2026 | Buy | +38,000 | $26.34 | $1.00M | 429,173 |
| Jennifer B. Damico SVP & Controller | Aug 5, 2026 | Sale | −3,278 | $25.40 | $83.26K | 28,611 |
| Ronald E. Blaylock Director | Aug 5, 2026 | Buy | +39,231 | $25.46 | $998.82K | 66,938 |
| Mortimer J. Buckley Director | Aug 5, 2026 | Buy | +37,632 | $25.52 | $960.37K | 37,632 |
| Jennifer B. Damico SVP & Controller | Jun 9, 2026 | Sale | −2,000 | $25.70 | $51.40K | 31,397 |
| Jennifer B. Damico SVP & Controller | Mar 4, 2026 | Tax withholding | −826 | $26.62 | $21.99K | 32,934 |
| Jennifer B. Damico SVP & Controller | Mar 3, 2026 | Award | +5,408 | – | – | 33,760 |
| Jennifer B. Damico SVP & Controller | Mar 3, 2026 | Award | +16,311 | – | – | 28,352 |
| Jennifer B. Damico SVP & Controller | Feb 27, 2026 | Tax withholding | −655 | $27.65 | $18.11K | 12,041 |
| Michael McDermott Executive Vice President | Feb 26, 2026 | Tax withholding | −3,503 | $27.10 | $94.93K | 74,308 |
| Payal Sahni Executive Vice President | Feb 25, 2026 | Option exercise | +56,888 | $33.82 | $1.92M | 82,816 |
| Payal Sahni Executive Vice President | Feb 25, 2026 | Tax withholding | −54,066 | $26.92 | $1.46M | 27,667 |
| Payal Sahni Executive Vice President | Feb 25, 2026 | Tax withholding | −1,083 | $27.09 | $29.34K | 81,733 |
| Jennifer B. Damico SVP & Controller | Feb 25, 2026 | Tax withholding | −361 | $27.09 | $9.78K | 29,383 |
| Jennifer B. Damico SVP & Controller | Feb 25, 2026 | Tax withholding | −16,687 | $26.92 | $449.21K | 12,696 |
| Jennifer B. Damico SVP & Controller | Feb 25, 2026 | Option exercise | +17,558 | $33.82 | $593.81K | 29,744 |
| Michael McDermott Executive Vice President | Feb 25, 2026 | Option exercise | +37,925 | $33.82 | $1.28M | 114,534 |
| Michael McDermott Executive Vice President | Feb 25, 2026 | Tax withholding | −679 | $27.09 | $18.39K | 113,855 |
| Michael McDermott Executive Vice President | Feb 25, 2026 | Tax withholding | −36,044 | $26.92 | $970.30K | 77,811 |
| Douglas M. Lankler Executive Vice President | Feb 25, 2026 | Option exercise | +122,907 | $33.82 | $4.16M | 282,186 |
| Douglas M. Lankler Executive Vice President | Feb 25, 2026 | Tax withholding | −2,198 | $27.09 | $59.54K | 279,988 |
| Douglas M. Lankler Executive Vice President | Feb 25, 2026 | Tax withholding | −116,811 | $26.92 | $3.14M | 163,177 |
| Christoffel Boshoff President, R&D | Feb 25, 2026 | Award | +13,383 | – | – | 168,212 |
| Christoffel Boshoff President, R&D | Feb 25, 2026 | Tax withholding | −6,833 | $27.09 | $185.11K | 161,379 |
| Albert Bourla Chairman & CEO, Director | Feb 25, 2026 | Tax withholding | −467,241 | $26.92 | $12.58M | 388,671 |
| Albert Bourla Chairman & CEO, Director | Feb 25, 2026 | Option exercise | +491,626 | $33.82 | $16.63M | 864,215 |
| Albert Bourla Chairman & CEO, Director | Feb 25, 2026 | Tax withholding | −8,303 | $27.09 | $224.93K | 855,912 |
| Lidia Fonseca Executive Vice President | Feb 25, 2026 | Tax withholding | −54,066 | $26.92 | $1.46M | 46,455 |
| Lidia Fonseca Executive Vice President | Feb 25, 2026 | Tax withholding | −1,058 | $27.09 | $28.66K | 100,521 |
| Lidia Fonseca Executive Vice President | Feb 25, 2026 | Option exercise | +56,888 | $33.82 | $1.92M | 101,579 |
| Christoffel Boshoff President, R&D | Feb 23, 2026 | Tax withholding | −816 | $27.06 | $22.08K | 154,829 |
| Jennifer B. Damico SVP & Controller | Feb 23, 2026 | Tax withholding | −419 | $27.06 | $11.34K | 12,186 |
| Christoffel Boshoff President, R&D | Jan 30, 2026 | Tax withholding | −12,887 | $26.44 | $340.73K | 155,645 |
| Jennifer B. Damico SVP & Controller | Mar 4, 2025 | Sale | −2,500 | $25.93 | $64.83K | 11,850 |
| Jennifer B. Damico SVP & Controller | Mar 4, 2025 | Award | +5,583 | – | – | 14,350 |
| Jennifer B. Damico SVP & Controller | Feb 27, 2025 | Tax withholding | −749 | $26.10 | $19.55K | 29,761 |
| Payal Sahni Executive Vice President | Feb 27, 2025 | Tax withholding | −468 | $26.10 | $12.21K | 43,774 |
| Payal Sahni Executive Vice President | Feb 27, 2025 | Option exercise | +19,054 | $31.31 | $596.58K | 44,242 |
| Payal Sahni Executive Vice President | Feb 27, 2025 | Tax withholding | −17,846 | $26.06 | $465.07K | 25,928 |
| Douglas M. Lankler Executive Vice President | Feb 27, 2025 | Tax withholding | −3,589 | $26.10 | $93.67K | 306,201 |
| Douglas M. Lankler Executive Vice President | Feb 27, 2025 | Tax withholding | −146,961 | $26.06 | $3.83M | 159,240 |
| Douglas M. Lankler Executive Vice President | Feb 27, 2025 | Option exercise | +156,914 | $31.31 | $4.91M | 309,790 |
| Jennifer B. Damico SVP & Controller | Feb 27, 2025 | Option exercise | +22,416 | $31.31 | $701.84K | 31,063 |
| Jennifer B. Damico SVP & Controller | Feb 27, 2025 | Tax withholding | −20,994 | $26.06 | $547.10K | 9,516 |
| Jennifer B. Damico SVP & Controller | Feb 27, 2025 | Tax withholding | −553 | $26.10 | $14.43K | 30,510 |
| Michael McDermott Executive Vice President | Feb 27, 2025 | Tax withholding | −45,347 | $26.06 | $1.18M | 75,958 |
| Michael McDermott Executive Vice President | Feb 27, 2025 | Tax withholding | −1,108 | $26.10 | $28.92K | 121,305 |
| Michael McDermott Executive Vice President | Feb 27, 2025 | Option exercise | +48,419 | $31.31 | $1.52M | 122,413 |
| Albert Bourla Chairman & CEO, Director | Feb 27, 2025 | Tax withholding | −18,300 | $26.10 | $477.63K | 913,444 |
| Albert Bourla Chairman & CEO, Director | Feb 27, 2025 | Option exercise | +582,823 | $31.31 | $18.25M | 931,744 |
| Albert Bourla Chairman & CEO, Director | Feb 27, 2025 | Tax withholding | −545,855 | $26.06 | $14.22M | 367,589 |
| Sally Susman Executive Vice President | Feb 27, 2025 | Tax withholding | −79,779 | $26.06 | $2.08M | 168,909 |
| Sally Susman Executive Vice President | Feb 27, 2025 | Tax withholding | −2,178 | $26.10 | $56.85K | 248,688 |
| Sally Susman Executive Vice President | Feb 27, 2025 | Option exercise | +85,182 | $31.31 | $2.67M | 250,866 |
| Christoffel Boshoff President, R&D | Feb 27, 2025 | Award | +17,450 | – | – | 172,147 |
| Christoffel Boshoff President, R&D | Feb 27, 2025 | Tax withholding | −8,909 | $26.10 | $232.52K | 163,238 |
| Lidia Fonseca Executive Vice President | Feb 27, 2025 | Option exercise | +72,629 | $31.31 | $2.27M | 111,534 |
| Lidia Fonseca Executive Vice President | Feb 27, 2025 | Tax withholding | −68,022 | $26.06 | $1.77M | 41,829 |
| Lidia Fonseca Executive Vice President | Feb 27, 2025 | Tax withholding | −1,683 | $26.10 | $43.93K | 109,851 |
| Michael McDermott Executive Vice President | Feb 26, 2025 | Tax withholding | −3,220 | $26.42 | $85.07K | 73,994 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Mikael Dolsten Former Officer | May 23, 2025 | 59,781 | $1.38M | May 23, 2025 | Restricted Stock Vesting |
| Mikael Dolsten Former Officer | May 5, 2025 | 55,000 | $1.31M | May 5, 2025 | Restricted Stock Vesting |
| William Pao Former Chief Development Officer; EVP | Sep 13, 2023 | 54,379 | $1.85M | Sep 13, 2023 | Restricted Stock Vesting |